Delivery Order SPE2DE24D0021-SPE2D625F5G8X
- Not listed
- Fisher Scientific Company L.L.C. received a fixed-price delivery order contract from the Medical Supply Chain, a defense-focused federal agency, for the procurement of BinaxNOW COVID-19 antigen testing kits. The contract, valued at $2,156.00, was awarded on September 10, 2025, with an ultimate completion date of September 17, 2025. Performance will take place in Pittsburgh, Pennsylvania. This delivery order represents a child contract with no set-aside designation, awarded through open...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,176.00 on August 19, 2025, for the supply of BinaxNOW COVID-19 antigen testing kits. This fixed-price contract with economic price adjustment provisions is scheduled for completion by August 26, 2025, with performance taking place in Pittsburgh, Pennsylvania. The award was made without a set-aside designation, indicating open competition procurement. The funding agency is the Medical Supply Chain, operating under the...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $2,897.80 on August 11, 2025, for the provision of BinaxNOW COVID antigen testing kits to support the Medical Supply Chain, a defense-oriented federal agency. This fixed-price delivery order with economic price adjustment capability represents a child contract under a larger vehicle and will be performed in Pittsburgh, Pennsylvania, with an ultimate completion date of August 18, 2025. No set-aside designation was applied...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,076.64 on August 21, 2025, for the procurement of BinaxNow COVID-19 antigen testing kits. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and is funded by the Defense Department's Medical Supply Chain division. Performance will be completed in Pittsburgh, Pennsylvania, with an ultimate completion date of August 28, 2025. This award represents a child contract with no...
- Fisher Scientific Company L.L.C. received a delivery order award on August 22, 2025, for the procurement of BinaxNOW COVID-19 antigen testing kits. The contract carries a ceiling value of $2,213.20 and is structured as a fixed-price agreement with economic price adjustment provisions. Funding originates from the Medical Supply Chain division within the Department of Defense. The place of performance is listed as Pittsburgh, PA. This delivery order represents a child contract, indicating it falls...
- Fisher Scientific Company L.L.C. received a delivery order award valued at $3,920 for BinaxNow COVID-19 test kits under a fixed-price contract with economic price adjustment. The order, issued on September 16, 2025, with an ultimate completion date of September 23, 2025, will be performed in Pittsburgh, Pennsylvania. This is a child contract with no set-aside designation, awarded through open competition to support the Medical Supply Chain, a defense-focused federal agency function. Fisher...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,470.00 by the Medical Supply Chain, a defense-affiliated federal agency, on June 2, 2025, for the supply of BinaxNOW COVID-19 antigen over-the-counter test kits (12 tests per box, 2 boxes per case). The contract is structured as a fixed-price agreement with economic price adjustment provisions and is set to be completed by June 9, 2025, with performance taking place in Pittsburgh, Pennsylvania. This award represents a...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $8,036.00 for BINAXNOW COVID-19 40S test kits on August 15, 2025, by the Defense Medical Supply Chain, with an ultimate completion date of August 22, 2025. This is a fixed price contract with economic price adjustment provisions and carries no set-aside designation, reflecting open competition procurement. The contract specifies performance in Pittsburgh, PA 15275. As a child contract under a larger procurement vehicle, this...
- Fisher Scientific Company L.L.C. received a $3,920 fixed-price delivery order from the Medical Supply Chain, a defense-focused federal agency, for BinaxNow COVID-19 antigen testing kits. The contract is effective through September 12, 2025, with pricing subject to economic price adjustment provisions. This delivery order, which represents a child contract under a larger vehicle, carries no set-aside designation, reflecting Fisher Scientific's competitive standing in federal procurement. The kits...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $2,205.00 for BinaxNow COVID-19 antigen OTC test kits (12 tests per 2-test case) by the Defense Medical Supply Chain federal agency. The contract, awarded on September 9, 2025, with an ultimate completion date of September 16, 2025, utilizes a fixed price with economic price adjustment pricing structure. The place of performance is Pittsburgh, Pennsylvania. This delivery order represents a child contract, indicating...
- SPE2DE24D0021Indefinite Delivery Contract
- SPE2DE24D0021-SPE2D625F5G8XDelivery Order
Fisher Scientific Company L.L.C. was awarded a delivery order valued at $2,322.00 for BinaxNOW COVID-19 antigen testing kits on April 30, 2025, with an ultimate completion date of May 7, 2025. This fixed-price contract with economic price adjustment was issued by the Medical Supply Chain, a defense-oriented federal agency, and will be performed in Pittsburgh, Pennsylvania. As a child contract, this delivery order is part of a larger contracting vehicle, leveraging Fisher Scientific's established capabilities as a major supplier of scientific products, laboratory supplies, and medical equipment to federal agencies. No set-aside designation was utilized for this award, reflecting Fisher Scientific's competitive positioning in open federal procurement. The company, registered in SAM.gov since 2001, has a demonstrated track record of delivering specialized medical and testing solutions across multiple federal departments and agencies, including the National Institutes of Health, Department of Veterans Affairs, and the Food and Drug Administration. This procurement aligns with the government's ongoing need for rapid diagnostic testing solutions and reflects the agency's continued investment in maintaining medical supply chain capabilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 4/30/25 |